Secukinumab vs Methotrexate
National NHS prescribing compared (Prescription Cost Analysis)
Methotrexate was dispensed 190,005.0× as often as Secukinumab in February 2026 — 190,005 items versus 1 in England.
1items
Secukinumab · February 2026
NHSBSA Prescription Cost Analysis
190,005items
Methotrexate · February 2026
NHSBSA Prescription Cost Analysis
Figure 1. Secukinumab versus Methotrexate: national items dispensed by month
▬ Secukinumab · ╌ Methotrexate
Source: NHSBSA Prescription Cost Analysis, to February 2026
| Measure | Secukinumab | Methotrexate |
|---|---|---|
| Items, February 2026 | 1 | 190,005 |
| Items, last 12 months | 16 | 2,236,642 |
| Net ingredient cost, February 2026 | £1,219 | £2,295,534 |
See the full profile for Secukinumab or Methotrexate.